Líber Seregni

Recent publications · Crossref

5 total works indexed

1. Phase 3 Trial of ¹⁷⁷ Lu-Dotatate for Midgut Neuroendocrine Tumors

   · 2017 · cited 2,872x

2. 177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial

   · 2021 · cited 509x

3. Human Colorectal Cancer Cells Induce T-Cell Death Through Release of Proapoptotic Microvesicles: Role in Immune Escape

   · 2005 · cited 436x

4. Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies

   · 2018 · cited 191x

5. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group

   · 2019 · cited 176x

via Crossref · CC0

Wikidata facts

Image

Líber Seregni 1971.jpg

via Wikidata · CC0